Evogene joins AI drug discovery roadshow
EVGN•Evogene will attend the AI Drug Discovery Roadshow across the U.S. East Coast on Nov. 2-5, 2026, where CEO Ofer Haviv will present its ChemPass AI platform to potential investors and strategic partners.
1. Roadshow participation
Evogene will attend the AI Drug Discovery Roadshow across the U.S. East Coast on Nov. 2-5, 2026. CEO Ofer Haviv will present the ChemPass AI small-molecule discovery platform to potential investors and strategic partners, with participation aimed at expanding U.S. pharmaceutical and biotechnology relationships and advancing drug discovery collaborations.
